Orange (ORAN)
(Real Time Quote from BATS)
$12.12 USD
+0.01 (0.08%)
Updated Sep 23, 2024 02:06 PM ET
2-Buy of 5 2
A Value D Growth F Momentum B VGM
Price, Consensus and EPS Surprise
ORAN 12.12 +0.01(0.08%)
Will ORAN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ORAN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ORAN
Zacks Industry Outlook Orange, SK Telecom Co and KT Corp
Orange, Grifols Egypt Team Up to Advance Egypt's Healthcare System
ORAN: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Wireless Non-US Stocks Set to Gain From Positive Industry Vibes
Should Value Investors Buy Orange (ORAN) Stock?
What Makes Orange (ORAN) a Good Fit for 'Trend Investing'
Other News for ORAN
It Is Time For 2026 Medicare IRMAA Tax Planning
Orange S.A.: The Upside Must Be Understood
ORANGE SA (0OQV) Gets a Buy from Kepler Capital
AT&T's Recovery Is Floundering
Grifols Egypt Collaborates with Orange Business to Deliver New Data Center and Communications Infrastructure, Supporting Advanced Medical Processes